- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 56.66M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 29.54M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 12.24M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$8.97M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.94M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $2.34M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $5.25M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.71M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.33M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$67.55K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.95M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $9.94M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.02M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.28M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $9.89M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.43M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.06M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.31 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.42 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.31 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.42 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $5.89M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.12M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.7M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.01M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$9.04M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.1M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.6M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.13M |